Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Oncological care organisation during COVID-19 outbreak.

Identifieur interne : 000A13 ( Main/Exploration ); précédent : 000A12; suivant : 000A14

Oncological care organisation during COVID-19 outbreak.

Auteurs : Concetta Elisa Onesti [Oman, Belgique] ; Hope S. Rugo [États-Unis] ; Daniele Generali [Italie] ; Marc Peeters [Belgique] ; Khalil Zaman [Suisse] ; Hans Wildiers [Belgique] ; Nadia Harbeck [Allemagne] ; Miguel Martin [Espagne] ; Massimo Cristofanilli [États-Unis] ; Javier Cortes [Espagne] ; Vivianne Tjan-Heijnen [Pays-Bas] ; Sara A. Hurvitz [États-Unis] ; Guy Berchem [Luxembourg (pays)] ; Marco Tagliamento [Italie] ; Mario Campone [France] ; Rupert Bartsch [Autriche] ; Sabino De Placido [Italie] ; Fabio Puglisi [Italie] ; Sylvie Rottey [Belgique] ; Volkmar Müller [Allemagne] ; Thomas Ruhstaller [Suisse] ; Jean-Pascal Machiels [Belgique] ; Pierfranco Conte [Italie] ; Ahmad Awada [Belgique] ; Guy Jerusalem [Belgique]

Source :

RBID : pubmed:32847836

Descripteurs français

English descriptors

Abstract

BACKGROUND

COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major oncological units in Europe and the USA.

METHODS

A 46-item survey was sent by email to representatives of 30 oncological centres in 12 of the most affected countries. The survey inquired about preventive measures established to reduce virus spread, patient education and processes employed for risk reduction in each oncological unit.

RESULTS

Investigators from 21 centres in 10 countries answered the survey between 10 April and 6 May 2020. A triage for patients with cancer before hospital or clinic visits was conducted by 90.5% of centres before consultations, 95.2% before day care admissions and in 100% of the cases before overnight hospitalisation by means of phone calls, interactive online platforms, swab test and/or chest CT scan. Permission for caregivers to attend clinic visits was limited in many centres, with some exceptions (ie, for non-autonomous patients, in the case of a new diagnosis, when bad news was expected and for terminally ill patients). With a variable delay period, the use of personal protective equipment was unanimously mandatory, and in many centres, only targeted clinical and instrumental examinations were performed. Telemedicine was implemented in 76.2% of the centres. Separated pathways for COVID-19-positive and COVID-19-negative patients were organised, with separate inpatient units and day care areas. Self-isolation was required for COVID-19-positive or symptomatic staff, while return to work policies required a negative swab test in 76.2% of the centres.

CONCLUSION

Many pragmatic measures have been quickly implemented to deal with the health emergency linked to COVID-19, although the relative efficacy of each intervention should be further analysed in large observational studies.


DOI: 10.1136/esmoopen-2020-000853
PubMed: 32847836
PubMed Central: PMC7451457


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Oncological care organisation during COVID-19 outbreak.</title>
<author>
<name sortKey="Onesti, Concetta Elisa" sort="Onesti, Concetta Elisa" uniqKey="Onesti C" first="Concetta Elisa" last="Onesti">Concetta Elisa Onesti</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Oncology, CHU de Liège, Liege, Belgium elisaonesti@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Medical Oncology, CHU de Liège, Liege</wicri:regionArea>
<wicri:noRegion>Liege</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Human Genetics, GIGA Research Institute and University of Liège, Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Human Genetics, GIGA Research Institute and University of Liège, Liège</wicri:regionArea>
<wicri:noRegion>Liège</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rugo, Hope S" sort="Rugo, Hope S" uniqKey="Rugo H" first="Hope S" last="Rugo">Hope S. Rugo</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Medicine and Division of Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine and Division of Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Generali, Daniele" sort="Generali, Daniele" uniqKey="Generali D" first="Daniele" last="Generali">Daniele Generali</name>
<affiliation wicri:level="1">
<nlm:affiliation>UO Patologia Mammaria e Ricerca Traslazionale, Breast Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>UO Patologia Mammaria e Ricerca Traslazionale, Breast Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona</wicri:regionArea>
<wicri:noRegion>Cremona</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Trieste, Trieste, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Trieste, Trieste</wicri:regionArea>
<wicri:noRegion>Trieste</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Peeters, Marc" sort="Peeters, Marc" uniqKey="Peeters M" first="Marc" last="Peeters">Marc Peeters</name>
<affiliation wicri:level="1">
<nlm:affiliation>Oncology Department, University Hospital Antwerp (UZA), Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Oncology Department, University Hospital Antwerp (UZA), Antwerp</wicri:regionArea>
<wicri:noRegion>Antwerp</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zaman, Khalil" sort="Zaman, Khalil" uniqKey="Zaman K" first="Khalil" last="Zaman">Khalil Zaman</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne</wicri:regionArea>
<placeName>
<settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wildiers, Hans" sort="Wildiers, Hans" uniqKey="Wildiers H" first="Hans" last="Wildiers">Hans Wildiers</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of General Medical Oncology, University Hospitals Leuven, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Harbeck, Nadia" sort="Harbeck, Nadia" uniqKey="Harbeck N" first="Nadia" last="Harbeck">Nadia Harbeck</name>
<affiliation wicri:level="3">
<nlm:affiliation>Breast Center, Dept. OB&GYN and CCLMU, Ludwig Maximilians University Hospital, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Breast Center, Dept. OB&GYN and CCLMU, Ludwig Maximilians University Hospital, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Martin, Miguel" sort="Martin, Miguel" uniqKey="Martin M" first="Miguel" last="Martin">Miguel Martin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departamento de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
<orgName type="university">Université complutense de Madrid</orgName>
</affiliation>
</author>
<author>
<name sortKey="Cristofanilli, Massimo" sort="Cristofanilli, Massimo" uniqKey="Cristofanilli M" first="Massimo" last="Cristofanilli">Massimo Cristofanilli</name>
<affiliation wicri:level="2">
<nlm:affiliation>Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois</wicri:regionArea>
<placeName>
<region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cortes, Javier" sort="Cortes, Javier" uniqKey="Cortes J" first="Javier" last="Cortes">Javier Cortes</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>IOB Institute of Oncology, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>IOB Institute of Oncology, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tjan Heijnen, Vivianne" sort="Tjan Heijnen, Vivianne" uniqKey="Tjan Heijnen V" first="Vivianne" last="Tjan-Heijnen">Vivianne Tjan-Heijnen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology Department, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Medical Oncology Department, Maastricht University Medical Center (MUMC), Maastricht</wicri:regionArea>
<wicri:noRegion>Maastricht</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hurvitz, Sara A" sort="Hurvitz, Sara A" uniqKey="Hurvitz S" first="Sara A" last="Hurvitz">Sara A. Hurvitz</name>
<affiliation wicri:level="2">
<nlm:affiliation>Los Angeles/Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Los Angeles/Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Berchem, Guy" sort="Berchem, Guy" uniqKey="Berchem G" first="Guy" last="Berchem">Guy Berchem</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hemato-Oncology Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Hemato-Oncology Department, Centre Hospitalier de Luxembourg, Luxembourg</wicri:regionArea>
<wicri:noRegion>Luxembourg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tagliamento, Marco" sort="Tagliamento, Marco" uniqKey="Tagliamento M" first="Marco" last="Tagliamento">Marco Tagliamento</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology 2, Ospedale Policlinico San Martino, Genova, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Medical Oncology 2, Ospedale Policlinico San Martino, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Campone, Mario" sort="Campone, Mario" uniqKey="Campone M" first="Mario" last="Campone">Mario Campone</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint Herblain, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint Herblain</wicri:regionArea>
<wicri:noRegion>Saint Herblain</wicri:noRegion>
<wicri:noRegion>Saint Herblain</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bartsch, Rupert" sort="Bartsch, Rupert" uniqKey="Bartsch R" first="Rupert" last="Bartsch">Rupert Bartsch</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Medicine I, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Medicine I, Medical University of Vienna, Vienna</wicri:regionArea>
<placeName>
<settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De Placido, Sabino" sort="De Placido, Sabino" uniqKey="De Placido S" first="Sabino" last="De Placido">Sabino De Placido</name>
<affiliation wicri:level="1">
<nlm:affiliation>Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli</wicri:regionArea>
<wicri:noRegion>Napoli</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Puglisi, Fabio" sort="Puglisi, Fabio" uniqKey="Puglisi F" first="Fabio" last="Puglisi">Fabio Puglisi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano</wicri:regionArea>
<wicri:noRegion>Aviano</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rottey, Sylvie" sort="Rottey, Sylvie" uniqKey="Rottey S" first="Sylvie" last="Rottey">Sylvie Rottey</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology Department, UZ Gent, Gent, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Medical Oncology Department, UZ Gent, Gent</wicri:regionArea>
<wicri:noRegion>Gent</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Volkmar" sort="Muller, Volkmar" uniqKey="Muller V" first="Volkmar" last="Müller">Volkmar Müller</name>
<affiliation wicri:level="3">
<nlm:affiliation>Ginecology Department, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Ginecology Department, University Medical Center Hamburg-Eppendorf, Hamburg</wicri:regionArea>
<placeName>
<settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ruhstaller, Thomas" sort="Ruhstaller, Thomas" uniqKey="Ruhstaller T" first="Thomas" last="Ruhstaller">Thomas Ruhstaller</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology Department, Breast Center of Eastern Switzerland, St Gallen, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Medical Oncology Department, Breast Center of Eastern Switzerland, St Gallen</wicri:regionArea>
<wicri:noRegion>St Gallen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Machiels, Jean Pascal" sort="Machiels, Jean Pascal" uniqKey="Machiels J" first="Jean-Pascal" last="Machiels">Jean-Pascal Machiels</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oncology Department, Cliniques Universitaires St. Luc, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Oncology Department, Cliniques Universitaires St. Luc, Brussels</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Conte, Pierfranco" sort="Conte, Pierfranco" uniqKey="Conte P" first="Pierfranco" last="Conte">Pierfranco Conte</name>
<affiliation wicri:level="1">
<nlm:affiliation>Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova</wicri:regionArea>
<wicri:noRegion>Padova</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Medical Oncology, University of Padova, Padova, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Division of Medical Oncology, University of Padova, Padova</wicri:regionArea>
<wicri:noRegion>Padova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Awada, Ahmad" sort="Awada, Ahmad" uniqKey="Awada A" first="Ahmad" last="Awada">Ahmad Awada</name>
<affiliation wicri:level="3">
<nlm:affiliation>Medical Oncology Department, Institut Jules Bordet, Bruxelles, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Medical Oncology Department, Institut Jules Bordet, Bruxelles</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Medical Oncology Department, Université Libre de Bruxelles, Bruxelles, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Medical Oncology Department, Université Libre de Bruxelles, Bruxelles</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author>
<name sortKey="Jerusalem, Guy" sort="Jerusalem, Guy" uniqKey="Jerusalem G" first="Guy" last="Jerusalem">Guy Jerusalem</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Oncology, CHU de Liège, Liege, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Medical Oncology, CHU de Liège, Liege</wicri:regionArea>
<wicri:noRegion>Liege</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Université de Liège, Liege, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Université de Liège, Liege</wicri:regionArea>
<orgName type="university">Université de Liège</orgName>
<placeName>
<settlement type="city">Liège</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province de Liège</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32847836</idno>
<idno type="pmid">32847836</idno>
<idno type="doi">10.1136/esmoopen-2020-000853</idno>
<idno type="pmc">PMC7451457</idno>
<idno type="wicri:Area/Main/Corpus">000354</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000354</idno>
<idno type="wicri:Area/Main/Curation">000354</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000354</idno>
<idno type="wicri:Area/Main/Exploration">000354</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Oncological care organisation during COVID-19 outbreak.</title>
<author>
<name sortKey="Onesti, Concetta Elisa" sort="Onesti, Concetta Elisa" uniqKey="Onesti C" first="Concetta Elisa" last="Onesti">Concetta Elisa Onesti</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Oncology, CHU de Liège, Liege, Belgium elisaonesti@gmail.com.</nlm:affiliation>
<country wicri:rule="url">Oman</country>
<wicri:regionArea>Department of Medical Oncology, CHU de Liège, Liege</wicri:regionArea>
<wicri:noRegion>Liege</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Laboratory of Human Genetics, GIGA Research Institute and University of Liège, Liège, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Laboratory of Human Genetics, GIGA Research Institute and University of Liège, Liège</wicri:regionArea>
<wicri:noRegion>Liège</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rugo, Hope S" sort="Rugo, Hope S" uniqKey="Rugo H" first="Hope S" last="Rugo">Hope S. Rugo</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Medicine and Division of Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Medicine and Division of Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Generali, Daniele" sort="Generali, Daniele" uniqKey="Generali D" first="Daniele" last="Generali">Daniele Generali</name>
<affiliation wicri:level="1">
<nlm:affiliation>UO Patologia Mammaria e Ricerca Traslazionale, Breast Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>UO Patologia Mammaria e Ricerca Traslazionale, Breast Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona</wicri:regionArea>
<wicri:noRegion>Cremona</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of Trieste, Trieste, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>University of Trieste, Trieste</wicri:regionArea>
<wicri:noRegion>Trieste</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Peeters, Marc" sort="Peeters, Marc" uniqKey="Peeters M" first="Marc" last="Peeters">Marc Peeters</name>
<affiliation wicri:level="1">
<nlm:affiliation>Oncology Department, University Hospital Antwerp (UZA), Antwerp, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Oncology Department, University Hospital Antwerp (UZA), Antwerp</wicri:regionArea>
<wicri:noRegion>Antwerp</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Zaman, Khalil" sort="Zaman, Khalil" uniqKey="Zaman K" first="Khalil" last="Zaman">Khalil Zaman</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne</wicri:regionArea>
<placeName>
<settlement type="city">Lausanne</settlement>
<region nuts="3" type="region">Canton de Vaud</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wildiers, Hans" sort="Wildiers, Hans" uniqKey="Wildiers H" first="Hans" last="Wildiers">Hans Wildiers</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of General Medical Oncology, University Hospitals Leuven, Leuven</wicri:regionArea>
<wicri:noRegion>Leuven</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Harbeck, Nadia" sort="Harbeck, Nadia" uniqKey="Harbeck N" first="Nadia" last="Harbeck">Nadia Harbeck</name>
<affiliation wicri:level="3">
<nlm:affiliation>Breast Center, Dept. OB&GYN and CCLMU, Ludwig Maximilians University Hospital, Munich, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Breast Center, Dept. OB&GYN and CCLMU, Ludwig Maximilians University Hospital, Munich</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Martin, Miguel" sort="Martin, Miguel" uniqKey="Martin M" first="Miguel" last="Martin">Miguel Martin</name>
<affiliation wicri:level="4">
<nlm:affiliation>Departamento de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Departamento de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
<orgName type="university">Université complutense de Madrid</orgName>
</affiliation>
</author>
<author>
<name sortKey="Cristofanilli, Massimo" sort="Cristofanilli, Massimo" uniqKey="Cristofanilli M" first="Massimo" last="Cristofanilli">Massimo Cristofanilli</name>
<affiliation wicri:level="2">
<nlm:affiliation>Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois</wicri:regionArea>
<placeName>
<region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Cortes, Javier" sort="Cortes, Javier" uniqKey="Cortes J" first="Javier" last="Cortes">Javier Cortes</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>IOB Institute of Oncology, Madrid, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>IOB Institute of Oncology, Madrid</wicri:regionArea>
<placeName>
<settlement type="city">Madrid</settlement>
<region nuts="2" type="region">Communauté de Madrid</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Tjan Heijnen, Vivianne" sort="Tjan Heijnen, Vivianne" uniqKey="Tjan Heijnen V" first="Vivianne" last="Tjan-Heijnen">Vivianne Tjan-Heijnen</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology Department, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Medical Oncology Department, Maastricht University Medical Center (MUMC), Maastricht</wicri:regionArea>
<wicri:noRegion>Maastricht</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hurvitz, Sara A" sort="Hurvitz, Sara A" uniqKey="Hurvitz S" first="Sara A" last="Hurvitz">Sara A. Hurvitz</name>
<affiliation wicri:level="2">
<nlm:affiliation>Los Angeles/Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Los Angeles/Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Berchem, Guy" sort="Berchem, Guy" uniqKey="Berchem G" first="Guy" last="Berchem">Guy Berchem</name>
<affiliation wicri:level="1">
<nlm:affiliation>Hemato-Oncology Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.</nlm:affiliation>
<country xml:lang="fr">Luxembourg (pays)</country>
<wicri:regionArea>Hemato-Oncology Department, Centre Hospitalier de Luxembourg, Luxembourg</wicri:regionArea>
<wicri:noRegion>Luxembourg</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tagliamento, Marco" sort="Tagliamento, Marco" uniqKey="Tagliamento M" first="Marco" last="Tagliamento">Marco Tagliamento</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology 2, Ospedale Policlinico San Martino, Genova, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Medical Oncology 2, Ospedale Policlinico San Martino, Genova</wicri:regionArea>
<wicri:noRegion>Genova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Campone, Mario" sort="Campone, Mario" uniqKey="Campone M" first="Mario" last="Campone">Mario Campone</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint Herblain, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint Herblain</wicri:regionArea>
<wicri:noRegion>Saint Herblain</wicri:noRegion>
<wicri:noRegion>Saint Herblain</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Bartsch, Rupert" sort="Bartsch, Rupert" uniqKey="Bartsch R" first="Rupert" last="Bartsch">Rupert Bartsch</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Medicine I, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Medicine I, Medical University of Vienna, Vienna</wicri:regionArea>
<placeName>
<settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De Placido, Sabino" sort="De Placido, Sabino" uniqKey="De Placido S" first="Sabino" last="De Placido">Sabino De Placido</name>
<affiliation wicri:level="1">
<nlm:affiliation>Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli</wicri:regionArea>
<wicri:noRegion>Napoli</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Puglisi, Fabio" sort="Puglisi, Fabio" uniqKey="Puglisi F" first="Fabio" last="Puglisi">Fabio Puglisi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano</wicri:regionArea>
<wicri:noRegion>Aviano</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rottey, Sylvie" sort="Rottey, Sylvie" uniqKey="Rottey S" first="Sylvie" last="Rottey">Sylvie Rottey</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology Department, UZ Gent, Gent, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Medical Oncology Department, UZ Gent, Gent</wicri:regionArea>
<wicri:noRegion>Gent</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Volkmar" sort="Muller, Volkmar" uniqKey="Muller V" first="Volkmar" last="Müller">Volkmar Müller</name>
<affiliation wicri:level="3">
<nlm:affiliation>Ginecology Department, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Ginecology Department, University Medical Center Hamburg-Eppendorf, Hamburg</wicri:regionArea>
<placeName>
<settlement type="city">Hambourg</settlement>
<region type="land" nuts="2">Hambourg</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ruhstaller, Thomas" sort="Ruhstaller, Thomas" uniqKey="Ruhstaller T" first="Thomas" last="Ruhstaller">Thomas Ruhstaller</name>
<affiliation wicri:level="1">
<nlm:affiliation>Medical Oncology Department, Breast Center of Eastern Switzerland, St Gallen, Switzerland.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Medical Oncology Department, Breast Center of Eastern Switzerland, St Gallen</wicri:regionArea>
<wicri:noRegion>St Gallen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Machiels, Jean Pascal" sort="Machiels, Jean Pascal" uniqKey="Machiels J" first="Jean-Pascal" last="Machiels">Jean-Pascal Machiels</name>
<affiliation wicri:level="3">
<nlm:affiliation>Oncology Department, Cliniques Universitaires St. Luc, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Oncology Department, Cliniques Universitaires St. Luc, Brussels</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Conte, Pierfranco" sort="Conte, Pierfranco" uniqKey="Conte P" first="Pierfranco" last="Conte">Pierfranco Conte</name>
<affiliation wicri:level="1">
<nlm:affiliation>Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova</wicri:regionArea>
<wicri:noRegion>Padova</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Medical Oncology, University of Padova, Padova, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Division of Medical Oncology, University of Padova, Padova</wicri:regionArea>
<wicri:noRegion>Padova</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Awada, Ahmad" sort="Awada, Ahmad" uniqKey="Awada A" first="Ahmad" last="Awada">Ahmad Awada</name>
<affiliation wicri:level="3">
<nlm:affiliation>Medical Oncology Department, Institut Jules Bordet, Bruxelles, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Medical Oncology Department, Institut Jules Bordet, Bruxelles</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Medical Oncology Department, Université Libre de Bruxelles, Bruxelles, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Medical Oncology Department, Université Libre de Bruxelles, Bruxelles</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author>
<name sortKey="Jerusalem, Guy" sort="Jerusalem, Guy" uniqKey="Jerusalem G" first="Guy" last="Jerusalem">Guy Jerusalem</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Oncology, CHU de Liège, Liege, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Medical Oncology, CHU de Liège, Liege</wicri:regionArea>
<wicri:noRegion>Liege</wicri:noRegion>
</affiliation>
<affiliation wicri:level="4">
<nlm:affiliation>Université de Liège, Liege, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Université de Liège, Liege</wicri:regionArea>
<orgName type="university">Université de Liège</orgName>
<placeName>
<settlement type="city">Liège</settlement>
<region type="region" nuts="1">Région wallonne</region>
<region type="province" nuts="1">Province de Liège</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">ESMO open</title>
<idno type="eISSN">2059-7029</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Betacoronavirus (MeSH)</term>
<term>Cancer Care Facilities (organization & administration)</term>
<term>Cancer Care Facilities (statistics & numerical data)</term>
<term>Coronavirus Infections (diagnosis)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Delivery of Health Care (MeSH)</term>
<term>Disinfection (MeSH)</term>
<term>Europe (epidemiology)</term>
<term>Health Care Surveys (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Medical Oncology (statistics & numerical data)</term>
<term>Neoplasms (therapy)</term>
<term>Pandemics (prevention & control)</term>
<term>Personal Protective Equipment (MeSH)</term>
<term>Pneumonia, Viral (diagnosis)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Triage (MeSH)</term>
<term>United States (epidemiology)</term>
<term>Visitors to Patients (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Betacoronavirus (MeSH)</term>
<term>Désinfection (MeSH)</term>
<term>Enquêtes sur les soins de santé (MeSH)</term>
<term>Europe (épidémiologie)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (diagnostic)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Oncologie médicale (statistiques et données numériques)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Pneumopathie virale (diagnostic)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Prestations des soins de santé (MeSH)</term>
<term>Triage (MeSH)</term>
<term>Tumeurs (thérapie)</term>
<term>Visiteurs des patients (MeSH)</term>
<term>Équipement de protection individuelle (MeSH)</term>
<term>Établissements de cancérologie (organisation et administration)</term>
<term>Établissements de cancérologie (statistiques et données numériques)</term>
<term>États-Unis (épidémiologie)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en">
<term>Europe</term>
<term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr">
<term>Établissements de cancérologie</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en">
<term>Cancer Care Facilities</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en">
<term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr">
<term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en">
<term>Cancer Care Facilities</term>
<term>Medical Oncology</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr">
<term>Oncologie médicale</term>
<term>Établissements de cancérologie</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="thérapie" xml:lang="fr">
<term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr">
<term>Europe</term>
<term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Betacoronavirus</term>
<term>Delivery of Health Care</term>
<term>Disinfection</term>
<term>Health Care Surveys</term>
<term>Humans</term>
<term>Personal Protective Equipment</term>
<term>Triage</term>
<term>Visitors to Patients</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Betacoronavirus</term>
<term>Désinfection</term>
<term>Enquêtes sur les soins de santé</term>
<term>Humains</term>
<term>Prestations des soins de santé</term>
<term>Triage</term>
<term>Visiteurs des patients</term>
<term>Équipement de protection individuelle</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr">
<term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>
<b>BACKGROUND</b>
</p>
<p>COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major oncological units in Europe and the USA.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>METHODS</b>
</p>
<p>A 46-item survey was sent by email to representatives of 30 oncological centres in 12 of the most affected countries. The survey inquired about preventive measures established to reduce virus spread, patient education and processes employed for risk reduction in each oncological unit.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>RESULTS</b>
</p>
<p>Investigators from 21 centres in 10 countries answered the survey between 10 April and 6 May 2020. A triage for patients with cancer before hospital or clinic visits was conducted by 90.5% of centres before consultations, 95.2% before day care admissions and in 100% of the cases before overnight hospitalisation by means of phone calls, interactive online platforms, swab test and/or chest CT scan. Permission for caregivers to attend clinic visits was limited in many centres, with some exceptions (ie, for non-autonomous patients, in the case of a new diagnosis, when bad news was expected and for terminally ill patients). With a variable delay period, the use of personal protective equipment was unanimously mandatory, and in many centres, only targeted clinical and instrumental examinations were performed. Telemedicine was implemented in 76.2% of the centres. Separated pathways for COVID-19-positive and COVID-19-negative patients were organised, with separate inpatient units and day care areas. Self-isolation was required for COVID-19-positive or symptomatic staff, while return to work policies required a negative swab test in 76.2% of the centres.</p>
</div>
<div type="abstract" xml:lang="en">
<p>
<b>CONCLUSION</b>
</p>
<p>Many pragmatic measures have been quickly implemented to deal with the health emergency linked to COVID-19, although the relative efficacy of each intervention should be further analysed in large observational studies.</p>
</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">32847836</PMID>
<DateCompleted>
<Year>2020</Year>
<Month>09</Month>
<Day>02</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>03</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Electronic">2059-7029</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>5</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>ESMO open</Title>
<ISOAbbreviation>ESMO Open</ISOAbbreviation>
</Journal>
<ArticleTitle>Oncological care organisation during COVID-19 outbreak.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">e000853</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1136/esmoopen-2020-000853</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND">COVID-19 appeared in late 2019, causing a pandemic spread. This led to a reorganisation of oncology care in order to reduce the risk of spreading infection between patients and healthcare staff. Here we analysed measures taken in major oncological units in Europe and the USA.</AbstractText>
<AbstractText Label="METHODS">A 46-item survey was sent by email to representatives of 30 oncological centres in 12 of the most affected countries. The survey inquired about preventive measures established to reduce virus spread, patient education and processes employed for risk reduction in each oncological unit.</AbstractText>
<AbstractText Label="RESULTS">Investigators from 21 centres in 10 countries answered the survey between 10 April and 6 May 2020. A triage for patients with cancer before hospital or clinic visits was conducted by 90.5% of centres before consultations, 95.2% before day care admissions and in 100% of the cases before overnight hospitalisation by means of phone calls, interactive online platforms, swab test and/or chest CT scan. Permission for caregivers to attend clinic visits was limited in many centres, with some exceptions (ie, for non-autonomous patients, in the case of a new diagnosis, when bad news was expected and for terminally ill patients). With a variable delay period, the use of personal protective equipment was unanimously mandatory, and in many centres, only targeted clinical and instrumental examinations were performed. Telemedicine was implemented in 76.2% of the centres. Separated pathways for COVID-19-positive and COVID-19-negative patients were organised, with separate inpatient units and day care areas. Self-isolation was required for COVID-19-positive or symptomatic staff, while return to work policies required a negative swab test in 76.2% of the centres.</AbstractText>
<AbstractText Label="CONCLUSION">Many pragmatic measures have been quickly implemented to deal with the health emergency linked to COVID-19, although the relative efficacy of each intervention should be further analysed in large observational studies.</AbstractText>
<CopyrightInformation>© Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Onesti</LastName>
<ForeName>Concetta Elisa</ForeName>
<Initials>CE</Initials>
<Identifier Source="ORCID">0000-0002-8360-5026</Identifier>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, CHU de Liège, Liege, Belgium elisaonesti@gmail.com.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Laboratory of Human Genetics, GIGA Research Institute and University of Liège, Liège, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rugo</LastName>
<ForeName>Hope S</ForeName>
<Initials>HS</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine and Division of Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Generali</LastName>
<ForeName>Daniele</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>UO Patologia Mammaria e Ricerca Traslazionale, Breast Unit, Azienda Socio Sanitaria Territoriale di Cremona, Cremona, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>University of Trieste, Trieste, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Peeters</LastName>
<ForeName>Marc</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0003-4969-2303</Identifier>
<AffiliationInfo>
<Affiliation>Oncology Department, University Hospital Antwerp (UZA), Antwerp, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zaman</LastName>
<ForeName>Khalil</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wildiers</LastName>
<ForeName>Hans</ForeName>
<Initials>H</Initials>
<AffiliationInfo>
<Affiliation>Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Harbeck</LastName>
<ForeName>Nadia</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>Breast Center, Dept. OB&GYN and CCLMU, Ludwig Maximilians University Hospital, Munich, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Martin</LastName>
<ForeName>Miguel</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Departamento de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cristofanilli</LastName>
<ForeName>Massimo</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cortes</LastName>
<ForeName>Javier</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Oncology Department, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>IOB Institute of Oncology, Madrid, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tjan-Heijnen</LastName>
<ForeName>Vivianne</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Medical Oncology Department, Maastricht University Medical Center (MUMC), Maastricht, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hurvitz</LastName>
<ForeName>Sara A</ForeName>
<Initials>SA</Initials>
<AffiliationInfo>
<Affiliation>Los Angeles/Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Berchem</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Hemato-Oncology Department, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Tagliamento</LastName>
<ForeName>Marco</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">0000-0001-7461-023X</Identifier>
<AffiliationInfo>
<Affiliation>Medical Oncology 2, Ospedale Policlinico San Martino, Genova, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Campone</LastName>
<ForeName>Mario</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint Herblain, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bartsch</LastName>
<ForeName>Rupert</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine I, Medical University of Vienna, Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Placido</LastName>
<ForeName>Sabino</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Puglisi</LastName>
<ForeName>Fabio</ForeName>
<Initials>F</Initials>
<Identifier Source="ORCID">0000-0003-0573-4938</Identifier>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, Centro di Riferimento Oncologico, Aviano, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rottey</LastName>
<ForeName>Sylvie</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Medical Oncology Department, UZ Gent, Gent, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Müller</LastName>
<ForeName>Volkmar</ForeName>
<Initials>V</Initials>
<AffiliationInfo>
<Affiliation>Ginecology Department, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ruhstaller</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Medical Oncology Department, Breast Center of Eastern Switzerland, St Gallen, Switzerland.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Machiels</LastName>
<ForeName>Jean-Pascal</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Oncology Department, Cliniques Universitaires St. Luc, Brussels, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Conte</LastName>
<ForeName>PierFranco</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico, Padova, Italy.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Medical Oncology, University of Padova, Padova, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Awada</LastName>
<ForeName>Ahmad</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Medical Oncology Department, Institut Jules Bordet, Bruxelles, Belgium.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Medical Oncology Department, Université Libre de Bruxelles, Bruxelles, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jerusalem</LastName>
<ForeName>Guy</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Oncology, CHU de Liège, Liege, Belgium.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Université de Liège, Liege, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>ESMO Open</MedlineTA>
<NlmUniqueID>101690685</NlmUniqueID>
<ISSNLinking>2059-7029</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList>
<SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002173" MajorTopicYN="N">Cancer Care Facilities</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D004203" MajorTopicYN="N">Disinfection</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005060" MajorTopicYN="N" Type="Geographic">Europe</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D019538" MajorTopicYN="N">Health Care Surveys</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008495" MajorTopicYN="N">Medical Oncology</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000067393" MajorTopicYN="N">Personal Protective Equipment</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014218" MajorTopicYN="N">Triage</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014789" MajorTopicYN="N">Visitors to Patients</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">COVID-19</Keyword>
<Keyword MajorTopicYN="Y">oncological care</Keyword>
</KeywordList>
<CoiStatement>Competing interests: HSR reported fundings to the Institution from Eisai, Genentech, Lilly, Macrogenics, Merk, Novartis, OBI Pharma, Odonate Therapeutics, Immunomedics, Daiichi-Sankyo and Pfizer; travel fees from Pfizer, Novartis, MacroGenics, Mylan, Daiichi-Sankyo and AstraZeneca; consulting roles for Samsung and Celtrion. MM reported personal fees from Roche, Novartis, Puma, AstraZeneca, Amgen, Taiho Oncology, Daiichi-Sankyo, PharmaMar, Eli-Lilly and Pfizer; grants from Roche, Novartis and Puma. MC reported a grant from Pfizer; personal fees from CytoDyn, Pfizer, Eli-Lilly, Novartis, Foundation Medicine, G1 Therapeutics, Sermionex and Genentech. JC reported funding to the institution from Roche, Ariad Pharmaceuticals, AstraZeneca, Baxalta GMBH/Servier Affaires, Bayer healthcare, Eisai, F. Hoffman-La Roche, Guardanth health, Merck Sharp & Dohme, Pfizer, Piqur Therapeutics, Puma C and Queen Mary University of London; honoraria from Roche, Novartis, Celgene, Eisai, Pfizer, Samsung Bioepis, Eli-Lilly, Merck Sharp & Dohme, and Daiichi Sankyo; travel fees from Roche, Novartis, Eisai, Pfizer, Daiichi Sankyo; consulting/advisor role for Roche, Celgene, Cellestia, AstraZeneca, Biothera Pharmaceutical, Merus, Seattle Genetics, Daiichi-Sankyo, Erytech, Athenex, Polyphor, Lilly, Servier, Merck Sharp&Dohme, GSK, Leuko, Bioasis, Clovis Oncology and Boehringer Ingelheim; stock, patents and intellectual property of MedSIR. SAH reported grants from Ambrx, Amgen, Arvinas, Bayer, Daiichi-Sankyo, Genentech/Roche, GSK, Immunomedics, Eli-Lilly, Macrogenics, Novartis, Pfizer, OBI Pharma, Pieris, Puma, Radius, Sanofi, Seattle Genetics and Dignitana; travel fees from Lilly and Novartis; stock options from NK Max; editorial support from Roche/Genetech, Eli-Lilly and Pfizer. MT declares travel, accomodations, expenses by Roche, Bristol-Myers Squibb, Astra Zeneca, Takeda; activity as medical writer supported by Novartis and Amgen, outside the present work. MC reported funding to the institution from Sanofi, Pierre-Fabre, AstraZeneca, Servier, Novartis, Abbvie, Accord and Pfizer; personal fees from GT1, Sanofi, Pierre-Fabre, AstraZeneca, Servier, Novartis, Abbvie, Accord and Pfizer. RB reported personal fees from Accord, AstraZeneca, Daiichi-Sankyo, Eisai, Eli-Lilly, MSD, Novartis, Roche, Puma, Pierre-Fabre and Sandoz; grants from Daiichi-Sankyo, Novartis and Roche; non-financial support from Eli-Lilly and MSD. SDP reported personal fees from Roche, Novartis, Pfizer, Celgene, AstraZeneca and Eli-Lilly. VM reported funding to the institution from Novartis, Roche, Seattle Genetics and Genentech; personal fees from Amgen, AstraZeneca, Daiichi-Sankyo, Eisai, Pfizer, MSD, Novartis, Roche, Teva and Seattle Genetics; consultancy honoraria from Genomic Health, Hexal, Roche, Pierre-Fabre, Amgen, ClinSol, Novartis, MSD, Daiichi-Sankyo, Eisai, Eli-Lilly, Tesaro, Seattle Genetics and Nektar. J-PM reported personal fees from Roche, AstraZeneca, Bayer, Innate, Merck-Serono, Boeringher, BMS, Novartis, Janssen, Incyte, Cue Biopharma, ALX Oncology and Pfizer; grant from BMS; travel fee from Amgen; other support from MSD, Psioxus, Debio and Nanobiotix. GJ reported personal fees from Novartis, Roche, Pfizer, Eli-Lilly, Amgen, BMS, AstraZeneca, Daiichi-Sankyo and Abbvie; grants from Novartis, Roche and Pfizer; non-financial support from Medimmune and Merck KGaA.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>06</Month>
<Day>02</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>07</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>9</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32847836</ArticleId>
<ArticleId IdType="pii">esmoopen-2020-000853</ArticleId>
<ArticleId IdType="doi">10.1136/esmoopen-2020-000853</ArticleId>
<ArticleId IdType="pmc">PMC7451457</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chest. 2020 Jul;158(1):406-415</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32335067</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2020 Jun;21(6):759-760</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32410877</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Iran Med. 2020 Apr 01;23(4):255-264</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32271599</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Oncol. 2020 Aug;31(8):1087-1088</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32360743</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2020 Jun;20(6):656-657</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32199493</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Oncol. 2020 Mar 25;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32211820</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Mar 19;382(12):1177-1179</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32074444</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA Oncol. 2020 Apr 1;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32236504</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ESMO Open. 2020 Apr;5(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32295769</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiology. 2020 Aug;296(2):E32-E40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32101510</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Radiology. 2020 Aug;296(2):E115-E117</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32073353</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Mar 30;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32227490</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ESMO Open. 2020 Mar;5(2):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32229501</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuro Oncol. 2020 May 05;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32369601</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncologist. 2020 Jun;25(6):e936-e945</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32243668</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2020 Jun;127:104346</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32361324</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Mar 23;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32203977</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Euro Surveill. 2020 Jan;25(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31992387</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Feb 20;382(8):727-733</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31978945</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ESMO Open. 2020 May;5(3):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32381594</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Apr;26(4):450-452</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32284615</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Mar 28;395(10229):1054-1062</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32171076</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):631-640</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32589990</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2020 Jun;26(6):845-848</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32350462</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Manag Care. 2020 Apr;26(4):147-148</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32270980</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Asian Pac J Cancer Prev. 2020 Mar 01;21(3):569-573</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32212779</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Oncol. 2020 May;31(5):553-555</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32201224</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Radiat Oncol Biol Phys. 2020 Jul 15;107(4):618-627</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32302681</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Microbiol. 2020 Apr 23;58(5):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32132196</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Oncol. 2020 Mar;21(3):335-337</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32066541</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 May 28;382(22):2081-2090</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32329971</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Autriche</li>
<li>Belgique</li>
<li>Espagne</li>
<li>France</li>
<li>Italie</li>
<li>Luxembourg (pays)</li>
<li>Oman</li>
<li>Pays-Bas</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region>
<li>Bavière</li>
<li>Californie</li>
<li>Canton de Vaud</li>
<li>Catalogne</li>
<li>Communauté de Madrid</li>
<li>District de Haute-Bavière</li>
<li>Hambourg</li>
<li>Illinois</li>
<li>Province de Liège</li>
<li>Région de Bruxelles-Capitale</li>
<li>Région wallonne</li>
<li>Vienne (Autriche)</li>
</region>
<settlement>
<li>Barcelone</li>
<li>Bruxelles</li>
<li>Hambourg</li>
<li>Lausanne</li>
<li>Liège</li>
<li>Madrid</li>
<li>Munich</li>
<li>Vienne (Autriche)</li>
</settlement>
<orgName>
<li>Université complutense de Madrid</li>
<li>Université de Liège</li>
<li>Université libre de Bruxelles</li>
</orgName>
</list>
<tree>
<country name="Oman">
<noRegion>
<name sortKey="Onesti, Concetta Elisa" sort="Onesti, Concetta Elisa" uniqKey="Onesti C" first="Concetta Elisa" last="Onesti">Concetta Elisa Onesti</name>
</noRegion>
</country>
<country name="Belgique">
<noRegion>
<name sortKey="Onesti, Concetta Elisa" sort="Onesti, Concetta Elisa" uniqKey="Onesti C" first="Concetta Elisa" last="Onesti">Concetta Elisa Onesti</name>
</noRegion>
<name sortKey="Awada, Ahmad" sort="Awada, Ahmad" uniqKey="Awada A" first="Ahmad" last="Awada">Ahmad Awada</name>
<name sortKey="Awada, Ahmad" sort="Awada, Ahmad" uniqKey="Awada A" first="Ahmad" last="Awada">Ahmad Awada</name>
<name sortKey="Jerusalem, Guy" sort="Jerusalem, Guy" uniqKey="Jerusalem G" first="Guy" last="Jerusalem">Guy Jerusalem</name>
<name sortKey="Jerusalem, Guy" sort="Jerusalem, Guy" uniqKey="Jerusalem G" first="Guy" last="Jerusalem">Guy Jerusalem</name>
<name sortKey="Machiels, Jean Pascal" sort="Machiels, Jean Pascal" uniqKey="Machiels J" first="Jean-Pascal" last="Machiels">Jean-Pascal Machiels</name>
<name sortKey="Peeters, Marc" sort="Peeters, Marc" uniqKey="Peeters M" first="Marc" last="Peeters">Marc Peeters</name>
<name sortKey="Rottey, Sylvie" sort="Rottey, Sylvie" uniqKey="Rottey S" first="Sylvie" last="Rottey">Sylvie Rottey</name>
<name sortKey="Wildiers, Hans" sort="Wildiers, Hans" uniqKey="Wildiers H" first="Hans" last="Wildiers">Hans Wildiers</name>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Rugo, Hope S" sort="Rugo, Hope S" uniqKey="Rugo H" first="Hope S" last="Rugo">Hope S. Rugo</name>
</region>
<name sortKey="Cristofanilli, Massimo" sort="Cristofanilli, Massimo" uniqKey="Cristofanilli M" first="Massimo" last="Cristofanilli">Massimo Cristofanilli</name>
<name sortKey="Hurvitz, Sara A" sort="Hurvitz, Sara A" uniqKey="Hurvitz S" first="Sara A" last="Hurvitz">Sara A. Hurvitz</name>
</country>
<country name="Italie">
<noRegion>
<name sortKey="Generali, Daniele" sort="Generali, Daniele" uniqKey="Generali D" first="Daniele" last="Generali">Daniele Generali</name>
</noRegion>
<name sortKey="Conte, Pierfranco" sort="Conte, Pierfranco" uniqKey="Conte P" first="Pierfranco" last="Conte">Pierfranco Conte</name>
<name sortKey="Conte, Pierfranco" sort="Conte, Pierfranco" uniqKey="Conte P" first="Pierfranco" last="Conte">Pierfranco Conte</name>
<name sortKey="De Placido, Sabino" sort="De Placido, Sabino" uniqKey="De Placido S" first="Sabino" last="De Placido">Sabino De Placido</name>
<name sortKey="Generali, Daniele" sort="Generali, Daniele" uniqKey="Generali D" first="Daniele" last="Generali">Daniele Generali</name>
<name sortKey="Puglisi, Fabio" sort="Puglisi, Fabio" uniqKey="Puglisi F" first="Fabio" last="Puglisi">Fabio Puglisi</name>
<name sortKey="Tagliamento, Marco" sort="Tagliamento, Marco" uniqKey="Tagliamento M" first="Marco" last="Tagliamento">Marco Tagliamento</name>
</country>
<country name="Suisse">
<region name="Canton de Vaud">
<name sortKey="Zaman, Khalil" sort="Zaman, Khalil" uniqKey="Zaman K" first="Khalil" last="Zaman">Khalil Zaman</name>
</region>
<name sortKey="Ruhstaller, Thomas" sort="Ruhstaller, Thomas" uniqKey="Ruhstaller T" first="Thomas" last="Ruhstaller">Thomas Ruhstaller</name>
</country>
<country name="Allemagne">
<region name="Bavière">
<name sortKey="Harbeck, Nadia" sort="Harbeck, Nadia" uniqKey="Harbeck N" first="Nadia" last="Harbeck">Nadia Harbeck</name>
</region>
<name sortKey="Muller, Volkmar" sort="Muller, Volkmar" uniqKey="Muller V" first="Volkmar" last="Müller">Volkmar Müller</name>
</country>
<country name="Espagne">
<region name="Communauté de Madrid">
<name sortKey="Martin, Miguel" sort="Martin, Miguel" uniqKey="Martin M" first="Miguel" last="Martin">Miguel Martin</name>
</region>
<name sortKey="Cortes, Javier" sort="Cortes, Javier" uniqKey="Cortes J" first="Javier" last="Cortes">Javier Cortes</name>
<name sortKey="Cortes, Javier" sort="Cortes, Javier" uniqKey="Cortes J" first="Javier" last="Cortes">Javier Cortes</name>
</country>
<country name="Pays-Bas">
<noRegion>
<name sortKey="Tjan Heijnen, Vivianne" sort="Tjan Heijnen, Vivianne" uniqKey="Tjan Heijnen V" first="Vivianne" last="Tjan-Heijnen">Vivianne Tjan-Heijnen</name>
</noRegion>
</country>
<country name="Luxembourg (pays)">
<noRegion>
<name sortKey="Berchem, Guy" sort="Berchem, Guy" uniqKey="Berchem G" first="Guy" last="Berchem">Guy Berchem</name>
</noRegion>
</country>
<country name="France">
<noRegion>
<name sortKey="Campone, Mario" sort="Campone, Mario" uniqKey="Campone M" first="Mario" last="Campone">Mario Campone</name>
</noRegion>
</country>
<country name="Autriche">
<region name="Vienne (Autriche)">
<name sortKey="Bartsch, Rupert" sort="Bartsch, Rupert" uniqKey="Bartsch R" first="Rupert" last="Bartsch">Rupert Bartsch</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A13 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000A13 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32847836
   |texte=   Oncological care organisation during COVID-19 outbreak.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32847836" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021